July 6, 2022 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Molecular Spectroscopy Product Launch

Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment

ETTLINGEN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRiskPACS™ RuO test is promising for research... Read more

November 19, 2021 Lab Top-10

Bruker Announces Acquisition of MOLECUBES NV

Expands Nuclear Molecular Imaging Portfolio with Modular Benchtop CUBES™ PET, SPECT and CT Preclinical Imaging Systems GHENT, Belgium–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and... Read more

June 1, 2021 Lab Top-10 Mass Spectrometry Product Launch

Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

Unique timsTOF trueSCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more

January 5, 2021 Cell Analysis Tools Lab Top-10 Mass Spectrometry

Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics

Breakthrough new paper by Mann-group demonstrates that unbiased, quantitative true single-cell proteomics can address important questions in cell biology and single-cell pathobiology Measured single-cell protein and RNA levels are very different, which implies distinct RNA and protein abundance regulation mechanisms. Protein measurements thus yield complementary quantitative biology information. Results also imply stable cellular core proteomes... Read more

January 4, 2021 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Mass Spectrometry

Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures

MBT Sepsityper Kit US IVD enables rapid, specific detection of many cases of bacteremia-induced sepsis to assist infectious disease specialists in potentially life-saving decisions Used for MALDI Biotyper® (MBT) identification directly from Positive Blood Cultures (PBC) with short time-to-result (TTR) of less than 30 minutes US FDA clearance received in late December for diagnostic use... Read more

December 18, 2020 Lab Top-10 Life Science Tools Product Launch

Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

Winter four-plex panel detects clinically most important respiratory viruses SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) Validation with nasopharyngeal swabs and oropharyngeal swabs for highest sensitivity Saliva sampling option convenient for patients, while also achieving high PCR sensitivity; saliva samples do not require extraction and enable a faster, resource-effective workflow NEHREN, Germany–(BUSINESS... Read more

November 27, 2020 Atomic Spectroscopy Product Launch

Bruker Launches the Q4 TASMAN™ Series 2 Advanced Spark-OES Metals Analyzer

KARLSRUHE, Germany – November 27, 2020 – Bruker today announces the launch of the new Q4 TASMANTM Series 2, a versatile, high-performance spark-Optical Emission Spectrometer (OES) for the metals industry. The Q4 TASMAN Series 2 extends Bruker’s line of benchtop OES systems, combining reliability and outstanding analytical performance with low cost of ownership.  The Q4 TASMAN Series 2 employs MultiVisionTM, the innovative... Read more

November 20, 2020 Molecular Spectroscopy Product Launch

Bruker Launches the RAPIDplus (mod 4)

BILLERICA Massachusetts – November 20, 2020 – Today, Bruker announced the launch of the novel RAPIDplus (mod 4) Fourier Transform Infrared (FTIR) based stand-off detector for Chemical Warfare Agents (CWA) and Toxic Industrial Chemicals (TIC). RAPIDplus (mod 4) allows automated, 24/7 monitoring of chemical hazards at distances up to 5 km. It is specifically designed for maritime,  coastal, and... Read more

October 21, 2020 Lab Top-10 Liq. Handling & Robotics Microscopy Product Launch

Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities

Accessible 3D Single-Molecule Localization Microscopy for Studying Subcellular Organelles and Spatial Multiomics MADISON, Wisc.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the release of the Vutara VXL Super-Resolution Fluorescence Microscopefor nanoscale biological imaging. The new system opens an affordable and easy-to-use path for both core facilities and individual investigators to enter the world of super-resolution... Read more

October 19, 2020 Atomic Spectroscopy Lab Top-10 Microscopy Molecular Spectroscopy

Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System

ZUERICH–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announces the European launch of the high-performance Fourier™ 80 system, a next-generation, 80 MHz Fourier Transform Nuclear Magnetic Resonance (FT-NMR) benchtop spectrometer, now with major new capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005105/en/ The new Fourier 80 brings the power of NMR to the... Read more